GREGORY CELESTIN: Open Payments
NPI 1710161864 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,729 in 70 payments from 4 companies in 2025. Trend: 2023 $10,470 · 2024 $8,710 · 2025 $10,729
Speaker / faculty: $6,110Food & beverage: $2,466Travel & lodging: $2,153
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 31 | $9,804 |
| ViiV Healthcare Company | 29 | $609 |
| ABBVIE INC. | 5 | $218 |
| Merck Sharp & Dohme LLC | 5 | $97 |
Products named: Biktarvy, CABENUVA, MAVYRET, DOVATO, Yeztugo, PIFELTRO, RUKOBIA, APRETUDE.
Industry payments across NY — which companies pay providers there.
